Country for PR: China
Contributor: PR Newswire Asia (China)
Friday, December 11 2020 - 13:30
Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan
SOMERSET, N.J., Dec. 11, 2020 /PRNewswire-AsiaNet/ --

Catalent, the leading global provider of advanced delivery technologies, 
development, manufacturing and clinical supply solutions for drugs, biologics, 
cell and gene therapies, and consumer health products, today announced the 
appointment of Nakaya "Nick" Matsumaru as General Manager of its new clinical 
packaging facility in Minakuchi, located in the Shiga prefecture of Japan.

Caption: Nakaya Matsumaru, GM of Shiga facility 

Reporting to Roel de Nobel, Catalent's Vice President of Operations for Europe 
and Asia-Pacific, Mr. Matsumaru joins the company from SymBio Pharmaceuticals 
Ltd, where he held the role of Senior Director Supply Chain & Quality 
Assurance. Prior to this, he spent four years in vice president, executive 
officer and head of operations posts with AstraZeneca, and seven years in 
Japan-based supply chain management with Johnson & Johnson and Janssen. He 
holds a bachelor's degree in sociology from Keio University in Tokyo.

"We are pleased to welcome Nick to head our clinical supplies business at our 
new facility in Shiga, which in partnership with our existing Japanese facility 
in Kakegawa, will provide flexible clinical supply solutions to customers in 
Japan and global biotech and pharmaceutical companies," commented Mr. de Nobel. 
He added, "Nick brings a great deal of experience, and will play an important 
role in the ongoing expansion of Catalent's Asia-Pacific network and ensuring 
that customers' clinical trials continue to be well-served across the region, 
and worldwide."

Catalent announced it had completed the acquisition of the 60,000-square-foot 
facility in Shiga from Teva-Takeda Pharmaceuticals in July 2020. The facility 
is the latest in Catalent's expanding Asia-Pacific clinical supplies network, 
and alongside the existing Japanese facility in Kakegawa, the  company's two 
sites in China and one in Singapore it will offer extensive services including 
access to primary and secondary packaging capabilities, Catalent's FastChain(R) 
demand-led supply services, a range of temperature options for storage and 
distribution, as well as clinical returns and destruction services.

About Catalent Clinical Supply Services

Catalent is a global leader in clinical supply services, with comprehensive and 
flexible solutions for small molecules, biologics, and cell and gene therapies 
and integrated solutions to accelerate speed to clinic. Catalent offers a full 
range services including clinical supply management, comprehensive packaging 
solutions, comparator sourcing, cold chain storage and global distribution and 
specialized supply chain services including direct-to-patient and demand-led 
supply. With nine GMP clinical packaging facilities and over 50 strategically 
located depots on six continents combined with more than 25 years' experience 
across thousands of studies in more than 80 countries, Catalent has the 
comprehensive services, global scale and expertise necessary to reliably supply 
clinical trials of all sizes and complexity anywhere in the world.

About Catalent 

Catalent (NYSE:CTLT) is the leading global provider of advanced delivery 
technologies, development, and manufacturing solutions for drugs, biologics, 
cell and gene therapies, and consumer health products. With over 85 years 
serving the industry, Catalent has proven expertise in bringing more customer 
products to market faster, enhancing product performance and ensuring reliable 
global clinical and commercial product supply. Catalent employs approximately 
14,000 people, including around 2,400 scientists and technicians, at more than 
45 facilities, and in fiscal year 2020 generated over $3 billion in annual 
revenue. Catalent is headquartered in Somerset, New Jersey. For more 
information, visit

More products. Better treatments. Reliably supplied.(TM)

Source: Catalent